A Common Antitussive Drug, Clobutinol, Precipitates the Long QT Syndrome 2

Chloé Bellocq(Institut du Thorax), Isabelle Baró(Inserm), Ronald Wilders(Utrecht University), Hervé Le Marec(Centre National de la Recherche Scientifique), Bénédicte Louërat-Oriou, Pierre Boisseau(Centre Hospitalier Universitaire de Nantes), Denis Escande(Institut du Thorax), Jean‐Jacques Schott(Centre National de la Recherche Scientifique)

Molecular Pharmacology

July 28, 2004

10.1124/mol.104.001065

Cited by 53

Related Papers

HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies

|Heart Rhythm|2011|1.5k

Congenital Heart Disease Caused by Mutations in the Transcription Factor <i>NKX2-5</i>

|Science|1998|1.3k

Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death

|Nature|2003|961

HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)

|EP Europace|2011|904

Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome

|Circulation|2010|850